|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5270181A
(en)
|
1991-02-06 |
1993-12-14 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
|
|
US5646016A
(en)
|
1991-02-06 |
1997-07-08 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
|
|
GB9105383D0
(en)
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
|
AU5361794A
(en)
|
1992-10-14 |
1994-05-09 |
Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
|
|
GB9410922D0
(en)
|
1994-06-01 |
1994-07-20 |
Townsend Alain R M |
Vaccines
|
|
AUPN015794A0
(en)
|
1994-12-20 |
1995-01-19 |
Csl Limited |
Variants of human papilloma virus antigens
|
|
WO1998006863A1
(en)
|
1996-08-14 |
1998-02-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
A vector for polynucleotide vaccines
|
|
NO315238B1
(no)
|
1998-05-08 |
2003-08-04 |
Gemvax As |
Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
|
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
|
DE10032608A1
(de)
|
2000-07-07 |
2002-01-24 |
Magnus Von Knebel Doeberitz Ch |
Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US20030125521A1
(en)
|
2001-06-20 |
2003-07-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
US20030215460A1
(en)
|
2002-05-07 |
2003-11-20 |
Schall Thomas J. |
Methods and compositions for inducing an immune response
|
|
US9575070B2
(en)
|
2001-12-04 |
2017-02-21 |
Wayne State University |
Neoepitope detection of disease using protein arrays
|
|
US20050069549A1
(en)
|
2002-01-14 |
2005-03-31 |
William Herman |
Targeted ligands
|
|
ES2283759T3
(es)
|
2002-01-18 |
2007-11-01 |
Pierre Fabre Medicament |
Anticuerpos anti-igf-ir y sus aplicaciones.
|
|
JP2005527490A
(ja)
|
2002-01-18 |
2005-09-15 |
イノヴィオ アーエス |
筋肉内投与のための二重特異性抗体dna構築物
|
|
AU2003224819A1
(en)
|
2002-04-01 |
2003-10-20 |
Euro-Celtique S.A. |
Epitope constructs comprising antigen presenting cell targeting mechanisms
|
|
AU2003232485A1
(en)
|
2002-04-18 |
2003-10-27 |
Mtm Laboratories Ag |
Neopeptides and methods useful for detection and treatment of cancer
|
|
ATE519115T1
(de)
|
2002-06-13 |
2011-08-15 |
Merck Patent Gmbh |
Verfahren für die identifizierung von allo- antigenen und ihre verwendung für krebstherapie und transplantation
|
|
CA2499837C
(en)
|
2002-10-03 |
2013-12-03 |
Wyeth Holdings Corporation |
Human papillomavirus polypeptides and immunogenic compositions
|
|
GB0222953D0
(en)
|
2002-10-03 |
2002-11-13 |
Glaxo Group Ltd |
Novel Compounds
|
|
AU2004215489B2
(en)
|
2003-02-25 |
2010-07-15 |
Nykode Therapeutics ASA |
Modified antibody
|
|
WO2004111075A2
(en)
|
2003-03-05 |
2004-12-23 |
Dendreon Corporation |
Alternative reading frame polypeptides for treatment
|
|
WO2005052119A2
(en)
|
2003-11-19 |
2005-06-09 |
Beth Israel Deaconess Medical Center |
Adjuvants of immune response
|
|
PL1576967T3
(pl)
|
2004-03-18 |
2008-03-31 |
Pasteur Institut |
Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne
|
|
JP2008503498A
(ja)
|
2004-06-17 |
2008-02-07 |
マンカインド コーポレイション |
癌の診断及び免疫療法における腫瘍関連抗原プロファイル
|
|
WO2006081323A2
(en)
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
EP2385059A3
(en)
|
2005-06-17 |
2012-02-15 |
Mannkind Corporation |
Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
|
|
SI2447283T1
(sl)
|
2005-09-07 |
2015-12-31 |
Amgen Fremont Inc. |
Človeška monoklonska protitelesa proti aktivin receptorski kinazi-1 (ALK-1)
|
|
EP1762575A1
(en)
|
2005-09-12 |
2007-03-14 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated antigens for diagnosis and therapy
|
|
JP2009532664A
(ja)
|
2006-02-27 |
2009-09-10 |
アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティ |
癌の治療のためのノボペプチドの同定および使用
|
|
KR102511874B1
(ko)
|
2006-07-28 |
2023-03-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 백신 및 이의 사용 방법
|
|
US20090010948A1
(en)
|
2006-12-15 |
2009-01-08 |
The University Of Hong Kong |
Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10
|
|
JP4954293B2
(ja)
|
2006-12-29 |
2012-06-13 |
オスプレイ・ファーマシューティカルズ・ユーエスエイ・インコーポレイテッド |
改変毒素を選択および生産する方法、改変毒素を含む複合体、およびそれらの使用
|
|
KR101514473B1
(ko)
|
2007-05-15 |
2015-04-22 |
트랜스진 에스.에이. |
다중 유전자 발현용 벡터
|
|
KR101163295B1
(ko)
|
2007-06-29 |
2012-07-05 |
에프. 호프만-라 로슈 아게 |
향상된 면역글로불린을 생산하는 중쇄 돌연변이체
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
CA2739608A1
(en)
|
2008-10-07 |
2010-04-15 |
The Regents Of The University Of California |
Recombinant nell protein production
|
|
US9115402B2
(en)
|
2010-05-14 |
2015-08-25 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of identifying tumor specific neoantigens
|
|
WO2011161244A1
(en)
|
2010-06-25 |
2011-12-29 |
Vaccibody As |
Homodimeric protein constructs
|
|
WO2012159643A1
(en)
|
2011-05-24 |
2012-11-29 |
Biontech Ag |
Individualized vaccines for cancer
|
|
LT2714071T
(lt)
|
2011-05-24 |
2019-10-10 |
Biontech Rna Pharmaceuticals Gmbh |
Individualizuotos vakcinos nuo vėžio
|
|
EP3533462A1
(en)
|
2011-12-21 |
2019-09-04 |
Vaccibody AS |
Vaccines against hpv
|
|
CN104159607A
(zh)
|
2012-01-24 |
2014-11-19 |
桑福德研究院/南达科他大学 |
用于治疗致癌病毒多肽阳性肿瘤的多核苷酸
|
|
US10501801B2
(en)
|
2012-09-28 |
2019-12-10 |
University Of Connecticut |
Identification of tumor-protective epitopes for the treatment of cancers
|
|
AU2013351542B2
(en)
|
2012-11-28 |
2018-08-09 |
BioNTech SE |
Individualized vaccines for cancer
|
|
WO2014165291A1
(en)
|
2013-03-12 |
2014-10-09 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines for human papilloma virus and methods for using the same
|
|
AU2014251207B2
(en)
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
EP3053592B1
(en)
|
2013-10-01 |
2025-04-23 |
Mie University |
T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
|
|
JP6740127B2
(ja)
|
2013-12-06 |
2020-08-12 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
新生物ワクチン用製剤
|
|
EP3936145A1
(en)
|
2014-07-31 |
2022-01-12 |
The University Of Western Australia |
A method for the identification of immunotherapy-drug combinations using a network approach
|
|
CA2961179A1
(en)
|
2014-09-14 |
2016-03-17 |
Washington University |
Personalized cancer vaccines and methods therefor
|
|
MA40737A
(fr)
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
|
WO2016090177A1
(en)
|
2014-12-03 |
2016-06-09 |
Verik Bio, Inc. |
Identification, selection and use of high curative potential t cell epitopes
|
|
WO2016128060A1
(en)
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
TW201708536A
(zh)
|
2015-05-26 |
2017-03-01 |
艾法西斯公司 |
個人化的基於遞送載體之免疫療法及其用途
|
|
US10563266B2
(en)
|
2015-07-14 |
2020-02-18 |
Personal Genome Diagnostics Inc. |
Neoantigen treatment prioritization using multivariate analysis based on: HLA genotype, self-similarity, similarity to known antigens, antigen expression levels and mutant allele frequency
|
|
KR20180087246A
(ko)
|
2015-10-12 |
2018-08-01 |
난토믹스, 엘엘씨 |
네오에피토프의 반복적 발견 및 이에 대한 적응성 면역치료 및 방법
|
|
CN108601820A
(zh)
|
2015-10-12 |
2018-09-28 |
南托米克斯有限责任公司 |
用于病毒癌症新表位的组合物和方法
|
|
WO2017066290A1
(en)
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Viral neoepitopes and uses thereof
|
|
JP7114477B2
(ja)
|
2015-12-16 |
2022-08-08 |
グリットストーン バイオ インコーポレイテッド |
新生抗原の特定、製造、および使用
|
|
WO2017118702A1
(en)
|
2016-01-08 |
2017-07-13 |
Vaccibody As |
Neoepitope rna cancer vaccine
|
|
JP2019505512A
(ja)
*
|
2016-01-08 |
2019-02-28 |
バッシボディ アクスイェ セルスカプ |
治療用抗癌ネオエピトープワクチン
|
|
US11291721B2
(en)
|
2016-03-21 |
2022-04-05 |
Marengo Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
JP2019513021A
(ja)
|
2016-03-24 |
2019-05-23 |
ナントセル,インコーポレイテッド |
ネオエピトープ提示のための配列の配置および配列
|
|
SG11201808196UA
(en)
|
2016-03-31 |
2018-10-30 |
Neon Therapeutics Inc |
Neoantigens and methods of their use
|
|
WO2017194170A1
(en)
|
2016-05-13 |
2017-11-16 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
|
|
EP3735984A1
(en)
|
2016-05-27 |
2020-11-11 |
Etubics Corporation |
Neoepitope vaccine compositions and methods of use thereof
|
|
CA3031003A1
(en)
|
2016-07-20 |
2018-01-25 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
WO2018102613A2
(en)
|
2016-12-01 |
2018-06-07 |
Nantomics, Llc |
Tumor antigenicity processing and presentation
|
|
US12053512B2
(en)
|
2016-12-08 |
2024-08-06 |
Nantbio, Inc. |
Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells
|
|
WO2018112449A2
(en)
|
2016-12-16 |
2018-06-21 |
Nant Holdings Ip, Llc |
Live cell imaging systems and methods to validate triggering of immune response
|
|
US12331359B2
(en)
|
2017-01-18 |
2025-06-17 |
Michael Laessig |
Neoantigens and uses thereof for treating cancer
|
|
WO2018148381A1
(en)
|
2017-02-07 |
2018-08-16 |
Nantcell, Inc. |
Maximizing t-cell memory and compositions and methods therefor
|
|
CN110809716B
(zh)
|
2017-02-12 |
2023-07-07 |
百欧恩泰美国公司 |
基于hla的方法和组合物及其用途
|
|
EP3678699A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|